InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by CHAUSSY STEVE, Chief Financial Officer. Director active across 1 companies, notably BioSig Technologies, Inc.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €6k. The latest transaction was filed on 21 May 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€2,7731,000 shares@ €2.7729100.0% of flow
Common Stock
SEC:0001185185-21-000712·
Ideal exit: 15 Feb 2022 (T+270)
€2,7731,000 shares@ €2.772950.0% of flow
Common Stock
SEC:0001185185-21-000712:0·
Ideal exit: 15 Feb 2022 (T+270)
2 of 2 declarations
About CHAUSSY STEVE
Steve Chaussey serves as Chief Financial Officer at BioSig Technologies, Inc. He manages the financial operations and strategy of the company, which specializes in medical technologies. Steve Chaussey plays a crucial role in financial planning and performance analysis.
